Literature DB >> 8313152

Neuronal histamine in the hypothalamus suppresses food intake in rats.

K Ookuma1, T Sakata, K Fukagawa, H Yoshimatsu, M Kurokawa, H Machidori, K Fujimoto.   

Abstract

Using probes to manipulate hypothalamic neuronal histamine, we report here that changes in neuronal histamine modulate physiological feeding behavior in rats. Infusion of alpha-fluoromethylhistidine (FMH), a "suicide" inhibitor of histidine decarboxylase (HDC), into the third cerebroventricle induced feeding in the early light phase when the histamine synthesis was most accelerated. FMH at an optimum 2.24 mumol dose elicited feeding in 100% of rats. Treatment of FMH specifically and selectively decreased concentration of histamine without affecting concentrations of catecholamines in the hypothalamus. Immediately before the dark phase, when the histamine synthesis was normally lower, FMH infusion did not affect feeding-related parameters such as meal size, meal duration or latency to eat. Conversely, thioperamide, which facilitates both synthesis and release of neuronal histamine by blocking presynaptic autoinhibitory H3 receptors, significantly decreased food intake after infusion of a 100-nmol dose into the third cerebroventricle. The effect of thioperamide was abolished with i.p. injection of 26 mumol/kg chlorpheniramine, an H1antagonist. FMH at 224 nmol was microinfused bilaterally into the feeding-related nuclei in the hypothalamus. The ventromedial nucleus (VMH) and the paraventricular nucleus (PVN), but not the lateral hypothalamus, the dorsomedial hypothalamus or the preoptic anterior hypothalamus were identified as the active sites for the modulation. Neuronal histamine may convey suppressive signals of food intake through H1 receptors in the VMH and the PVN with diurnal fluctuation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8313152     DOI: 10.1016/0006-8993(93)90960-u

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  22 in total

Review 1.  Pharmacological approaches for the treatment of obesity.

Authors:  José-Antonio Fernández-López; Xavier Remesar; Màrius Foz; Marià Alemany
Journal:  Drugs       Date:  2002       Impact factor: 9.546

2.  Chronic administration of olanzapine induces metabolic and food intake alterations: a mouse model of the atypical antipsychotic-associated adverse effects.

Authors:  R Coccurello; A Caprioli; O Ghirardi; R Conti; B Ciani; S Daniele; A Bartolomucci; A Moles
Journal:  Psychopharmacology (Berl)       Date:  2006-05-13       Impact factor: 4.530

3.  Short photoperiod-induced decrease of histamine H3 receptors facilitates activation of hypothalamic neurons in the Siberian hamster.

Authors:  P Barrett; M van den Top; D Wilson; J G Mercer; C K Song; T J Bartness; P J Morgan; D Spanswick
Journal:  Endocrinology       Date:  2009-04-16       Impact factor: 4.736

Review 4.  Withdrawal symptoms and rebound syndromes associated with switching and discontinuing atypical antipsychotics: theoretical background and practical recommendations.

Authors:  Anja Cerovecki; Richard Musil; Ansgar Klimke; Florian Seemüller; Ekkehard Haen; Rebecca Schennach; Kai-Uwe Kühn; Hans-Peter Volz; Michael Riedel
Journal:  CNS Drugs       Date:  2013-07       Impact factor: 5.749

5.  Targeted disruption of H3 receptors results in changes in brain histamine tone leading to an obese phenotype.

Authors:  Kazuhiko Takahashi; Hiroaki Suwa; Tomoo Ishikawa; Hidehito Kotani
Journal:  J Clin Invest       Date:  2002-12       Impact factor: 14.808

6.  Involvement of histaminergic and noradrenergic receptors in the oxytocin-induced food intake in neonatal meat-type chicks.

Authors:  Seyed Vahid Mirnaghizadeh; Morteza Zendehdel; Vahab Babapour
Journal:  Vet Res Commun       Date:  2016-12-14       Impact factor: 2.459

Review 7.  Histamine receptor signaling in energy homeostasis.

Authors:  Iustin V Tabarean
Journal:  Neuropharmacology       Date:  2015-06-21       Impact factor: 5.250

8.  Acute effects of betahistine hydrochloride on food intake and appetite in obese women: a randomized, placebo-controlled trial.

Authors:  Asem H Ali; Lisa B Yanoff; Elizabeth A Stern; Abena Akomeah; Amber Courville; Merel Kozlosky; Sheila M Brady; Karim A Calis; James C Reynolds; Melissa K Crocker; Nir Barak; Jack A Yanovski
Journal:  Am J Clin Nutr       Date:  2010-09-29       Impact factor: 7.045

9.  Therapeutic potential of histamine H3 receptor agonist for the treatment of obesity and diabetes mellitus.

Authors:  Ryo Yoshimoto; Yasuhisa Miyamoto; Ken Shimamura; Akane Ishihara; Kazuhiko Takahashi; Hidehito Kotani; Airu S Chen; Howard Y Chen; Douglas J Macneil; Akio Kanatani; Shigeru Tokita
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-05       Impact factor: 11.205

Review 10.  The role of hypothalamic H1 receptor antagonism in antipsychotic-induced weight gain.

Authors:  Meng He; Chao Deng; Xu-Feng Huang
Journal:  CNS Drugs       Date:  2013-06       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.